Literature DB >> 21054571

Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.

M Der-Petrossian1, J Valencak, C Jonak, G Klosner, T Dani, L Müllauer, H Pehamberger, R Knobler, F Trautinger.   

Abstract

BACKGROUND: The Langerhans cell (LC) hypothesis suggests that cutaneous T-cell lymphomas (CTCL) are diseases of chronic T-cell stimulation by LC-mediated antigen presentation.
OBJECTIVE: To investigate a broad panel of CTCL and cutaneous B-cell lymphomas (CBCL) for the spatial association of langerin(+) dendritic cells (DC) with T and B cells in the skin, respectively.
METHODS: Fifty-five specimens of CTCL and 10 of CBCL were double-stained with monoclonal antibodies against langerin and CD3 or CD20, respectively, and evaluated by confocal laser scan microscopy.
RESULTS: Dermal infiltrates in mycosis fungoides (n = 38), primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma (n = 3) and primary cutaneous peripheral T-cell lymphoma, unspecified (n = 3) were characterized by a high frequency of dermal langerin(+) DCs. These cells were exclusively present in the malignant infiltrates. No direct co-localization of CD3 and langerin could be resolved. Dermal langerin(+) cells were detected only in one of six primary cutaneous anaplastic large cell lymphomas (C-ALCL), characterized by epidermotropism. In other C-ALCL cases (five of six), in lymphomatoid papulosis (n = 3), subcutaneous panniculitis-like T-cell lymphoma (n = 2), and all variants of CBCL no dermal langerin(+) DCs could be found.
CONCLUSIONS: Langerin(+) DCs are abundant in the dermal infiltrates of T-cell lymphomas with specific involvement of the epidermis. This might indicate that immature LC and neoplastic T cells interact and gives rise to further studies to characterize the phenotype of the langerin(+) cell population described here and its role in the pathology of CTCL.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054571     DOI: 10.1111/j.1468-3083.2010.03882.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  4 in total

1.  Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease.

Authors:  Alessandro Pileri; Claudio Agostinelli; Maurizio Sessa; Pietro Quaglino; Marco Santucci; Carlo Tomasini; Vieri Grandi; Paolo Fava; Chiara Astrua; Simona Righi; Annalisa Patrizi; Stefano A Pileri; Nicola Pimpinelli
Journal:  Virchows Arch       Date:  2017-03-20       Impact factor: 4.064

2.  Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.

Authors:  Yaping Zhang; Min Chen; Yu Yu; Xiaoyu Liu; Weiping Liu; Lijun Jiang; Wenyan Zhang
Journal:  J Cutan Pathol       Date:  2021-10-20       Impact factor: 1.458

3.  TOX Expression in Mycosis Fungoides and Sezary Syndrome.

Authors:  Alessandro Pileri; Martina Cavicchi; Clara Bertuzzi; Simona Righi; Corrado Zengarini; Elena Sabattini; Giovanna Roncador; Claudio Agostinelli
Journal:  Diagnostics (Basel)       Date:  2022-06-29

4.  NLRP3 Regulates IL-4 Expression in TOX+ CD4+ T Cells of Cutaneous T Cell Lymphoma to Potentially Promote Disease Progression.

Authors:  Enrique Huanosta-Murillo; Marcela Alcántara-Hernández; Brenda Hernández-Rico; Georgina Victoria-Acosta; Patricia Miranda-Cruz; María Antonieta Domínguez-Gómez; Fermín Jurado-Santacruz; Genaro Patiño-López; Vadim Pérez-Koldenkova; Alam Palma-Guzmán; Paula Licona-Limón; Ezequiel M Fuentes-Pananá; Alicia Lemini-López; Laura C Bonifaz
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.